Cancer Stem Cell News
Cell Therapy News
Dermal Cell News
Endothelial Cell News
ESC & iPSC News
Extracellular Matrix News
Hematopoiesis News
Hepatic Cell News
Human Immunology News
Immune Regulation News
Intestinal Cell News
Mammary Cell News
Mesenchymal Cell News
Muscle Cell News
Neural Cell News
Organoid News
Pancreatic Cell News
Prostate Cell News
Pulmonary Cell NewsUsing patient-derived iPSCs and an in vitro artificial thymic organoid system as a model, investigators demonstrate that gene editing rescued the progressive T cell differentiation potential of RAG2-deficient cells to normal levels, with generation of a diversified T cell repertoire.
[Journal of Clinical Immunology]
6606345 M4EJUCZK items 1 apa 0 default asc 1 159661 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3A%22zotpress-725df72b77baa9ba9b9e1b1b1d3b833d%22%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22M4EJUCZK%22%2C%22library%22%3A%7B%22id%22%3A6606345%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Gardner%20et%20al.%22%2C%22parsedDate%22%3A%222021-03-01%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EGardner%2C%20C.%20L.%2C%20Pavel-Dinu%2C%20M.%2C%20Dobbs%2C%20K.%2C%20Bosticardo%2C%20M.%2C%20Reardon%2C%20P.%20K.%2C%20Lack%2C%20J.%2C%20DeRavin%2C%20S.%20S.%2C%20Le%2C%20K.%2C%20Bello%2C%20E.%2C%20Pala%2C%20F.%2C%20Delmonte%2C%20O.%20M.%2C%20Malech%2C%20H.%2C%20Montel-Hagan%2C%20A.%2C%20Crooks%2C%20G.%2C%20Acuto%2C%20O.%2C%20Porteus%2C%20M.%20H.%2C%20%26amp%3B%20Notarangelo%2C%20L.%20D.%20%282021%29.%20Gene%20Editing%20Rescues%20In%20vitro%20T%20Cell%20Development%20of%20RAG2-Deficient%20Induced%20Pluripotent%20Stem%20Cells%20in%20an%20Artificial%20Thymic%20Organoid%20System.%20%3Ci%3EJournal%20of%20Clinical%20Immunology%3C%5C%2Fi%3E.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2Fs10875-021-00989-6%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2Fs10875-021-00989-6%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.stemcellsciencenews.com%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D6606345%26amp%3Bitem_key%3DM4EJUCZK%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Gene%20Editing%20Rescues%20In%20vitro%20T%20Cell%20Development%20of%20RAG2-Deficient%20Induced%20Pluripotent%20Stem%20Cells%20in%20an%20Artificial%20Thymic%20Organoid%20System%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cameron%20L.%22%2C%22lastName%22%3A%22Gardner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mara%22%2C%22lastName%22%3A%22Pavel-Dinu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kerry%22%2C%22lastName%22%3A%22Dobbs%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marita%22%2C%22lastName%22%3A%22Bosticardo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Paul%20K.%22%2C%22lastName%22%3A%22Reardon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Justin%22%2C%22lastName%22%3A%22Lack%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Suk%20See%22%2C%22lastName%22%3A%22DeRavin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kent%22%2C%22lastName%22%3A%22Le%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ezekiel%22%2C%22lastName%22%3A%22Bello%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Francesca%22%2C%22lastName%22%3A%22Pala%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ottavia%20M.%22%2C%22lastName%22%3A%22Delmonte%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Harry%22%2C%22lastName%22%3A%22Malech%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Amelie%22%2C%22lastName%22%3A%22Montel-Hagan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gay%22%2C%22lastName%22%3A%22Crooks%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Oreste%22%2C%22lastName%22%3A%22Acuto%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthew%20H.%22%2C%22lastName%22%3A%22Porteus%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Luigi%20D.%22%2C%22lastName%22%3A%22Notarangelo%22%7D%5D%2C%22abstractNote%22%3A%22Severe%20combined%20immune%20deficiency%20%28SCID%29%20caused%20by%20RAG1%20or%20RAG2%20deficiency%20is%20a%20genetically%20determined%20immune%20deficiency%20characterized%20by%20the%20virtual%20absence%20of%20T%20and%20B%20lymphocytes.%20Unless%20treated%20with%20hematopoietic%20stem%20cell%20transplantation%20%28HSCT%29%2C%20patients%20with%20RAG%20deficiency%20succumb%20to%20severe%20infections%20early%20in%20life.%20However%2C%20HSCT%20carries%20the%20risk%20of%20graft-versus-host%20disease.%20Moreover%2C%20a%20high%20rate%20of%20graft%20failure%20and%20poor%20immune%20reconstitution%20have%20been%20reported%20after%20unconditioned%20HSCT.%20Expression%20of%20the%20RAG%20genes%20is%20tightly%20regulated%2C%20and%20preclinical%20attempts%20of%20gene%20therapy%20with%20heterologous%20promoters%20have%20led%20to%20controversial%20results.%20Using%20patient-derived%20induced%20pluripotent%20stem%20cells%20%28iPSCs%29%20and%20an%20in%20vitro%20artificial%20thymic%20organoid%20system%20as%20a%20model%2C%20here%20we%20demonstrate%20that%20gene%20editing%20rescues%20the%20progressive%20T%20cell%20differentiation%20potential%20of%20RAG2-deficient%20cells%20to%20normal%20levels%2C%20with%20generation%20of%20a%20diversified%20T%20cell%20repertoire.%20These%20results%20suggest%20that%20targeted%20gene%20editing%20may%20represent%20a%20novel%20therapeutic%20option%20for%20correction%20of%20this%20immunodeficiency.%22%2C%22date%22%3A%222021-03-01%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1007%5C%2Fs10875-021-00989-6%22%2C%22ISSN%22%3A%221573-2592%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2Fs10875-021-00989-6%22%2C%22deleted%22%3A1%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222021-03-03T20%3A53%3A58Z%22%7D%7D%5D%7D
Gardner, C. L., Pavel-Dinu, M., Dobbs, K., Bosticardo, M., Reardon, P. K., Lack, J., DeRavin, S. S., Le, K., Bello, E., Pala, F., Delmonte, O. M., Malech, H., Montel-Hagan, A., Crooks, G., Acuto, O., Porteus, M. H., & Notarangelo, L. D. (2021). Gene Editing Rescues In vitro T Cell Development of RAG2-Deficient Induced Pluripotent Stem Cells in an Artificial Thymic Organoid System. Journal of Clinical Immunology. https://doi.org/10.1007/s10875-021-00989-6 Cite
